{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Bluebird Bio to practice the inventions embodied in US Provisional Patent Application Serial No. 61/622,600, entitled \"Chimeric Antigen Receptors Targeting B-cell Maturation Antigen\" [HHS Ref. E-040-2012/0-US-01], and International (PCT) Application No. PCT/ US13/32029, entitled \"Chimeric Antigen Receptors Targeting B-cell Maturation Antigen\" [HHS Ref. E-040-2012/0-PCT-02], and all continuing applications and foreign counterparts. The patent rights in these inventions have been assigned to the Government of the United States of America. The prospective exclusive license territory may be worldwide, and the field of use may be limited to:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/07/17/2014-16764.html","cfr_references":[],"citation":"79 FR 41700","comment_url":null,"comments_close_on":"2014-08-18","correction_of":null,"corrections":[],"dates":"Only written comments or applications for a license (or both) which are received by the NIH Office of Technology Transfer on or before August 18, 2014 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2014-16764","effective_on":null,"end_page":41701,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/07/17/2014-16764.xml","html_url":"https://www.federalregister.gov/documents/2014/07/17/2014-16764/prospective-grant-of-exclusive-license-the-development-of-chimeric-antigen-receptors-targeting","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-16764?publication_date=2014-07-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-07-17/2014-16764/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":652,"last_updated":"2026-09-21 08:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-07-17/pdf/2014-16764.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-16764.pdf?1405514977","publication_date":"2014-07-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/07/17/2014-16764.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2014-08-19T12:01:25Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":41700,"subtype":null,"title":"Prospective Grant of Exclusive License: The Development of Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen To Treat or Prevent Cancer and Autoimmune Disease","toc_doc":"Development of Chimeric Antigen Receptors Targeting B-cell Maturation Antigen to Treat or Prevent Cancer and Autoimmune Disease","toc_subject":"Grants of Exclusive Licenses:","topics":[],"type":"Notice","volume":79}